CD155 blockade improves survival in experimental sepsis by reversing dendritic cell dysfunction

Biochemical and Biophysical Research Communications

Volumn 490, Issue 2, 2017, Pages 283-289

  Meng, Yan ^a   Zhao, Zhenzhen ^a   Zhu, Wenzhong ^a   Yang, Tao ^a   Deng, Xiaoming ^a   Bao, Rui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CD155; Dendritic cells; Immunosuppression; Sepsis

Indexed keywords

ANTIINFECTIVE AGENT; CD155 ANTIBODY; CELL PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 6; PERITONEAL DIALYSIS FLUID; PROTEIN CD155; T CELL IMMUNOGLOBULIN AND ITIM DOMAIN PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIBODY; CYTOKINE; POLIOVIRUS RECEPTOR; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; CD3+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; EXPERIMENTAL SEPSIS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SURVIVAL RATE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; PATHOLOGY; SEPSIS;

ANIMALS; ANTIBODIES; CYTOKINES; DENDRITIC CELLS; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, VIRUS; SEPSIS; SURVIVAL RATE;

EID: 85020728500     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.06.037     Document Type: Article

References (30)

1. Zhang, L., Ai, Y., Tsung, A., Clinical application: restoration of immune homeostasis by autophagy as a potential therapeutic target in sepsis. Exp. Ther. Med. 11 (2016), 1159–1167.
2. Ye, C., Choi, J.G., Abraham, S., Wu, H., Diaz, D., Terreros, D., Shankar, P., Manjunath, N., Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 21052–21057.
3. Hotchkiss, R.S., Karl, I.E., The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348 (2003), 138–150.
4. Skirecki, T., Borkowska-Zielinska, U., Zlotorowicz, M., Hoser, G., Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances. Arch. Immunol. Ther. Exp. (Warsz) 60 (2012), 123–135.
5. Hotchkiss, R.S., Swanson, P.E., Freeman, B.D., Tinsley, K.W., Cobb, J.P., Matuschak, G.M., Buchman, T.G., Karl, I.E., Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27 (1999), 1230–1251.
6. Hotchkiss, R.S., Nicholson, D.W., Apoptosis and caspases regulate death and inflammation in sepsis. Nat. Rev. Immunol. 6 (2006), 813–822.
7. Wakefield, C.H., Barclay, G.R., Fearon, K.C., Goldie, A.S., Ross, J.A., Grant, I.S., Ramsay, G., Howie, J.C., Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Scottish sepsis intervention group. Br. J. Surg. 85 (1998), 818–825.
8. Bone, R.C., Sir isaac newton, sepsis, SIRS, and CARS. Crit. Care Med. 24 (1996), 1125–1128.
9. Zhu, J., Wang, J., Sheng, Y., Zou, Y., Bo, L., Wang, F., Lou, J., Fan, X., Bao, R., Wu, Y., Chen, F., Deng, X., Li, J., Baicalin improves survival in a murine model of polymicrobial sepsis via suppressing inflammatory response and lymphocyte apoptosis. PLoS One, 7, 2012, e35523.
10. Ziegler, E.J., Fisher, C.J. Jr., Sprung, C.L., Straube, R.C., Sadoff, J.C., Foulke, G.E., Wortel, C.H., Fink, M.P., Dellinger, R.P., Teng, N.N., et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N. Engl. J. Med. 324 (1991), 429–436.
11. Fisher, C.J. Jr., Slotman, G.J., Opal, S.M., Pribble, J.P., Bone, R.C., Emmanuel, G., Ng, D., Bloedow, D.C., Catalano, M.A., Group, I.-R.S.S.S., Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial. Crit. Care Med. 22 (1994), 12–21.
12. Fisher, C.J. Jr., Agosti, J.M., Opal, S.M., Lowry, S.F., Balk, R.A., Sadoff, J.C., Abraham, E., Schein, R.M., Benjamin, E., Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The soluble TNF receptor sepsis study group. N. Engl. J. Med. 334 (1996), 1697–1702.
13. Cinel, I., Opal, S.M., Molecular biology of inflammation and sepsis: a primer. Crit. Care Med. 37 (2009), 291–304.
14. Boomer, J.S., Green, J.M., Hotchkiss, R.S., The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?. Virulence 5 (2014), 45–56.
15. Li, M., Xia, P., Du, Y., Liu, S., Huang, G., Chen, J., Zhang, H., Hou, N., Cheng, X., Zhou, L., Li, P., Yang, X., Fan, Z., T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling. J. Biol. Chem. 289 (2014), 17647–17657.
16. Mandai, K., Rikitake, Y., Mori, M., Takai, Y., Nectins and nectin-like molecules in development and disease. Curr. Top. Dev. Biol. 112 (2015), 197–231.
17. Yu, X., Harden, K., Gonzalez, L.C., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C.J., Clark, H., Eaton, D., Grogan, J.L., The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10 (2009), 48–57.
18. Inozume, T., Yaguchi, T., Furuta, J., Harada, K., Kawakami, Y., Shimada, S., Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase. J. Invest. Dermatol. 136 (2016), 255–263.
19. Rittirsch, D., Huber-Lang, M.S., Flierl, M.A., Ward, P.A., Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 4 (2009), 31–36.
20. Zhong, J., Yang, P., Muta, K., Dong, R., Marrero, M., Gong, F., Wang, C.Y., Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock. PLoS One, 5, 2010, e9593.
21. Dong, X., Shen, K., Bulow, H.E., Intrinsic and extrinsic mechanisms of dendritic morphogenesis. Annu. Rev. Physiol. 77 (2015), 271–300.
22. Tinsley, K.W., Grayson, M.H., Swanson, P.E., Drewry, A.M., Chang, K.C., Karl, I.E., Hotchkiss, R.S., Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J. Immunol. 171 (2003), 909–914.
23. Zanoni, I., Ostuni, R., Capuano, G., Collini, M., Caccia, M., Ronchi, A.E., Rocchetti, M., Mingozzi, F., Foti, M., Chirico, G., Costa, B., Zaza, A., Ricciardi-Castagnoli, P., Granucci, F., CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 460 (2009), 264–268.
24. Seth, S., Qiu, Q., Danisch, S., Maier, M.K., Braun, A., Ravens, I., Czeloth, N., Hyde, R., Dittrich-Breiholz, O., Forster, R., Bernhardt, G., Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells. J. Biol. Chem. 286 (2011), 39153–39163.
25. Osuchowski, M.F., Welch, K., Siddiqui, J., Remick, D.G., Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177 (2006), 1967–1974.
26. Adib-Conquy, M., Cavaillon, J.M., Compensatory anti-inflammatory response syndrome. Thromb. Haemost. 101 (2009), 36–47.
27. Delano, M.J., Scumpia, P.O., Weinstein, J.S., Coco, D., Nagaraj, S., Kelly-Scumpia, K.M., O'Malley, K.A., Wynn, J.L., Antonenko, S., Al-Quran, S.Z., Swan, R., Chung, C.S., Atkinson, M.A., Ramphal, R., Gabrilovich, D.I., Reeves, W.H., Ayala, A., Phillips, J., Laface, D., Heyworth, P.G., Clare-Salzler, M., Moldawer, L.L., MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 204 (2007), 1463–1474.
28. Venet, F., Chung, C.S., Monneret, G., Huang, X., Horner, B., Garber, M., Ayala, A., Regulatory T cell populations in sepsis and trauma. J. Leukoc. Biol. 83 (2008), 523–535.
29. Mellman, I., Steinman, R.M., Dendritic cells: specialized and regulated antigen processing machines. Cell 106 (2001), 255–258.
30. Coombes, J.L., Robinson, N.J., Maloy, K.J., Uhlig, H.H., Powrie, F., Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204 (2005), 184–194.